Results 201 to 210 of about 31,464 (260)

Neighborhood Deprivation and Voice and Reflux Symptom Burden in a Tertiary Laryngology Cohort

open access: yesThe Laryngoscope, Volume 136, Issue 9, Page 3826-3840, September 2026.
ABSTRACT Objective The voice handicap index‐10 (VHI‐10) and reflux symptoms index (RSI) are validated, patient‐reported outcome measures (PROMs) commonly used in laryngology to assess the subjective impact of voice disorders and severity of symptoms associated with laryngopharyngeal reflux, respectively.
Sandra Stinnett   +6 more
wiley   +1 more source

High Prevalence of Arterial and Venous Corona Mortis Variants in Cadaveric Dissection. [PDF]

open access: yesCureus
Álvarez-Manilla-Cruz D   +8 more
europepmc   +1 more source

Nanoparticle‐Mediated Therapy for Glioma: Advances and Prospects

open access: yesMedComm – Oncology, Volume 5, Issue 3, September 2026.
Various nanocarriers, including liposomes, dendrimers, exosomes and gold nanoparticles, are designed to penetrate the blood‐brain barrier and deliver chemotherapy, radiotherapy, immunotherapy, gene therapy, phototherapy, magnetic hyperthermia and sonodynamic therapy for glioma.
Wenqian Jiang   +5 more
wiley   +1 more source

Course of Portal Hypertension and Its Prognostic Impact After Liver Transplantation

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
ABSTRACT Background While portal hypertension (PH) typically resolves after liver transplantation (LT), persistence of PH may affect post‐transplant outcomes. We assessed the evolution of PH after LT and its impact on adverse outcomes. Methods We recorded clinical, laboratory, and imaging parameters of LT recipients between 2016 and 2022 in Vienna and ...
Nina Dominik   +20 more
wiley   +1 more source

Observation of risk perception, knowledge and behaviour related to covid-19 in heart failure patients enrolled on a telecoaching program. [PDF]

open access: yesBMC Med Inform Decis Mak
Rosner S   +7 more
europepmc   +1 more source

Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties. [PDF]

open access: yesCell Death Discov
Bojkova D   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy